Specific Practice & Industry Groups Details:
Statement of Practice Summary:
Antitrust; Competition Law; Banking Law; Finance; Business and Tort Litigation - USA; Business Restructuring; Reorganization; Capital Markets; Corporate Criminal Investigations; Employee Benefits; Executive Compensation; Energy; Environmental Law; Health Law; Safety; Financial Institutions Litigation; Regulation; Global Disputes; Government Regulation; Health Care; Insurance Recovery; Intellectual Property; Issues; Appellate Practice; Labor and Employment; Life Sciences; Mergers and Acquisitions; Private Equity; Projects and Infrastructure; Real Estate; Securities Litigation; SEC Enforcement; Tax Law.
Documents by Lawyers at this office
Court Affirms FTC's New HSR Rule on Pharmaceutical Patent License Transfers
Michael H. Knight,Bevin M.B. Newman,Geoffrey D. Oliver,Michael Sennett,Pamela L. Taylor, July 28, 2015
The D.C. Circuit has rejected a challenge by the Pharmaceutical Research and Manufacturers of America ("PhRMA") to an FTC rule that makes the HSR Act reporting requirements cover pharmaceutical patent licenses that transfer "all commercially significant rights." The rule,...
Patent Litigants Feeling Effects of Teva in Claim Construction Decisions on Appeal
Gregory A. Castanias,Anthony M. Insogna,Sasha Mayergoyz,Jennifer L. Swize, July 15, 2015
In January 2015, the U.S. Supreme Court handed down its decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., holding that underlying factual disputes related to a district court's claim construction should be reviewed for clear error instead of de novo, as the Federal Circuit had long held....
Languages: Chinese (Mandarin), French, German, Greek, Hebrew, Italian, Russian, Spanish and Ukrainian.